Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden-Reference-Cited by-同舟云学术

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden

Published:2019-07-12 Issue:1 Volume:19 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Rönningås Ulrika^ORCID,Fransson Per,Holm Maja,Wennman-Larsen Agneta

Funder

Swedish Prostate Cancer Federation

Lions cancer Research Foundation Umeå University

Kamprad Family Foundation for Entrepeneurship, Research and Charity

Villy Sundberg Foundation

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12894-019-0493-1.pdf

Reference32 articles.

1. Cancer incidence in Sweden 2014 [In Swedish]. [ https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/statistik/2015-12-26.pdf ].

2. Lynch T, Burgess M. Prostate-specific antigen test: an informed choice. Prim Health Care. 2011;21(3):16–21.

3. Appleton L, Wyatt D, Perkins E, Parker C, Crane J, Jones A, Moorhead L, Brown V, Wall C, Pagett M. The impact of prostate cancer on men's everyday life. Eur J Cancer Care. 2015;24(1):71–84.

4. Roth A, Passik S. Anxiety in men with prostate cancer may interfere with effective managment of the disease. Prim Care Cancer. 1996;16:30.

5. van de Wal M, van Oort I, Schouten J, Thewes B, Gielissen M, Prins J. Fear of cancer recurrence in prostate cancer survivors. Acta Oncol. 2016;55(7):821–7.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current prostate cancer screening and treatment strategies may not support a holistic nationwide program;Cancer;2022-06

2. Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study;European Journal of Cancer Care;2022-04-12

3. Predictive Value of Malignancy Index in Tumour Staging in Prostate Cancer;EMJ Urology;2022-01-17

4. Predictive Value of Malignancy Index in Tumour Staging in Prostate Cancer;EMJ Urology;2022-01-17

5. Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America;Prostate Cancer;2021-11-09